The FDA has allowed BD Diagnostics, a unit of Becton, Dickinson and Co., to sell a stool test for the "rapid detection" of a toxin that can cause clostridium difficile infection. The BD GeneOhm Cdiff molecular test, which could remove the need for multiple screenings, is already approved for use in spotting methicillin-resistant Staphylococcus aureus.

Full Story:

Related Summaries